Investing in tomorrow's world: 225 Binney Street
We believe 225 Binney Street is a great example of our commitment to investing in real estate assets for tomorrow’s world.
We are focused on investment strategies and opportunities which safeguard and enhance value for our clients, whilst making a lasting and positive difference in the cities of tomorrow.
We acquired a 75% stake of 225 Binney Street located in Cambridge, Massachusetts, US, in 2015, from Alexandria Real Estate Equities, the largest office REIT solely focused on science and technology campuses. The investment represented our first entry into this exciting and growing arena.
Cambridge is home to a dynamic biotech industry within Boston’s innovation hub. The exposure to this sub-sector allows diversification beyond traditional office properties that cater to more typical office tenants in technology, finance, law or media industries.
The 305,000 sq ft (28,000 sq m) property is comprised of a six-storey, Class-A office building, and two renovated, historic brick-and-beam buildings. The building has achieved LEED Gold certification, in recognition of its efficient and environmentally-friendly construction and operation. The property is 100% net-leased through 2028 to Biogen, a multi-national bio-technology company specialising in the development of new drug therapies.